Don't look now but Biden's signature economic policy is paying off
It’s been just over one year since President Joe Biden signed the Inflation Reduction Act, and there are already a lot of wins to celebrate.
Tuesday, the Biden administration announced the first 10 drugs for Medicare drug price negotiations. They treat many conditions common in seniors, including diabetes, heart conditions, strokes, kidney disease, and arthritis, and the plan is that more medications will join the price negotiation list in the coming years—if pharmaceutical industry lawsuits and Republican judges don’t block it. If Medicare does start negotiating drug prices, the government is expected to save $98.5 billion over a decade, with price reductions trickling down to insurance premiums and out-of-pocket costs for some individuals.